Speculating in Takeover Targets Message Board

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Strategies & Market Trends : Speculating in Takeover Targets

ULBI 6.025

+6.4%

Jan 5 3:59 PM EST

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next

From: richardred	5/17/2012 12:26:02 PM
	of 7254

Agilent Inks Biggest-Ever Buyout Of Cancer Specialist By AMY REEVES, INVESTOR'S BUSINESS DAILY Posted 10:50 AM ET Scientific instrument maker Agilent Technologies ( A) announced a deal to buy Danish cancer-diagnostics company Dako for $2.2 billion. Agilent will buy Dako from a Swedish private-equity group called EQT. In its press release, Agilent said this will be the largest acquisition in its history. The statement also emphasized that this is a component in a larger strategy for Agilent. "Agilent's strategy in acquiring Dako is about strengthening the company's presence in life science and about revenue growth," said CEO Bill Sullivan. "Dako employs extremely talented people with specialized expertise that we highly value. Their knowledge and experience will be very important as we move forward together." Revenue growth is something Agilent could use these days, as its year-over-year increase declined to single digits in the last couple of quarters after two years of better than 20% gains. Agilent shares were up 2.5% in early trading Thursday. news.investors.com

Report TOU Violation

Share This Post

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next